Immune Pharmaceuticals Stock Filter Stocks by Fundamentals
Immune Pharmaceuticals fundamentals help investors to digest information that contributes to Immune Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Immune OTC Stock. The fundamental analysis module provides a way to measure Immune Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immune Pharmaceuticals otc stock.
Immune |
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Immune Fundamentals
| Return On Asset | -42.63 | |||
| Current Valuation | 8.67 M | |||
| Shares Outstanding | 72.38 M | |||
| Shares Owned By Insiders | 2.16 % | |||
| Shares Owned By Institutions | 0.06 % | |||
| Number Of Shares Shorted | 1.08 M | |||
| Price To Earning | (0.17) X | |||
| Price To Book | 0.40 X | |||
| Price To Sales | 858.11 X | |||
| Revenue | 19 K | |||
| EBITDA | (13.77 M) | |||
| Net Income | (34.39 M) | |||
| Cash And Equivalents | 76 K | |||
| Total Debt | 8.33 M | |||
| Debt To Equity | 989.50 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (14.69 M) | |||
| Short Ratio | 1.32 X | |||
| Earnings Per Share | (1.15) X | |||
| Beta | 2.99 | |||
| Market Capitalization | 553.21 K | |||
| Total Asset | 36.18 M | |||
| Retained Earnings | (62.99 M) | |||
| Working Capital | (1.45 M) | |||
| Current Asset | 4.83 M | |||
| Current Liabilities | 6.29 M | |||
| Z Score | -1.4 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immune Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immune Pharmaceuticals' short interest history, or implied volatility extrapolated from Immune Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Immune OTC Stock
If you are still planning to invest in Immune Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immune Pharmaceuticals' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |